Merriman Curhan Initiates Coverage on TranS1 (TSON) with a Buy

April 3, 2008 8:00 AM EDT
Get Alerts TSON Hot Sheet
Price: $2.06 --0%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 5 | Down: 17 | New: 8
Join SI Premium – FREE
Merriman Curhan initiates coverage on TranS1 (Nasdaq: TSON) with a Buy.

TranS1 Inc. is a medical device company focused on designing, developing and marketing products that implement its minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine.[SM]

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Merriman Curhan Ford